• CD8+ T Cell-Mediated Abscopal Effects via Radiotherapy and D

  2026-05-15

  This study demonstrates that combining radiotherapy with PD-1 and TIGIT checkpoint blockade induces robust systemic antitumor responses and durable immune memory through CD8+ T cells. Mechanistic insights highlight the essential role of M1 macrophage polarization and NF-κB signaling in amplifying therapeutic efficacy, providing a foundation for future translational strategies in cancer immunotherapy.

• SP1/ADAM10/DRP1 Axis Orchestrates Vascular Crosstalk in HPH

  2026-05-15

  This study uncovers the SP1/ADAM10/DRP1 signaling axis as a central mediator of intercellular communication between endothelial and smooth muscle cells in hypoxia pulmonary hypertension (HPH). The findings highlight how ADAM10-driven modulation of DRP1 and PI3K/AKT/mTOR pathways alters smooth muscle cell phenotype, suggesting new molecular targets for intervention and providing a robust framework for apoptosis and mitochondrial dynamics research.

• Chromogranin A Drives α-Synuclein Pathology in Parkinson’s D

  2026-05-14

  Liu et al. (2025) identify chromogranin A (CgA) as a critical factor promoting the pathological conversion of α-synuclein into a unique, protease-resistant fibril strain at the synapse, accelerating Parkinson's disease progression. Their findings clarify early aggregation mechanisms and offer new perspectives for targeting synaptic pathology in neurodegenerative research.

• 3X (DYKDDDDK) Peptide: Optimizing FLAG Tag Protein Workflows

  2026-05-14

  The 3X (DYKDDDDK) Peptide empowers high-fidelity detection and purification of recombinant proteins via robust affinity and minimal structural interference. Leverage its trimeric design for reproducibility in advanced workflows, from immunodetection to protein crystallization. Discover how recent structural biology insights further elevate the strategic deployment of this next-generation epitope tag.

• HyperScript First-Strand cDNA Synthesis Kit: Optimized Workf

  2026-05-13

  Leverage the HyperScript First-Strand cDNA Synthesis Kit for reliable, high-yield cDNA synthesis, even from challenging RNA samples. This article delivers practical protocol enhancements, troubleshooting strategies, and real-world assay guidance, with direct relevance to advanced gene expression studies and translational research.

• Electrostatic Modulation of α-Synuclein Condensates in LLPS

  2026-05-13

  This article discusses how negatively charged α-synuclein condensates, formed via liquid–liquid phase separation, selectively modulate molecular partitioning based on electrostatic potential. The study advances mechanistic understanding of charge-dependent sorting in condensates and its implications for Parkinson’s disease research and experimental probe design.

• Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-05-12

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables efficient synthesis of randomly Cy3-labeled RNA probes, addressing the need for sensitive fluorescent detection in research applications such as in situ hybridization (ISH) and Northern blotting. It is strictly for research workflows and should not be used in diagnostic or clinical settings.

• Phenytoin in Sodium Channel Modulation: CNS Myelin Remodelin

  2026-05-12

  Phenytoin (5,5-diphenylimidazolidine-2,4-dione) is a gold-standard tool for dissecting voltage-gated sodium channel pathways and myelin dynamics in advanced CNS disease models. This guide translates recent breakthroughs into actionable assay design, protocol precision, and troubleshooting strategies for reproducible, high-fidelity neurological research.

• M344 as a Histone Deacetylase Inhibitor in Neuroblastoma Sup

  2026-05-11

  The referenced study demonstrates that M344, a histone deacetylase inhibitor, exerts strong cytostatic and cytotoxic effects on neuroblastoma cells, outperforming established HDAC inhibitors in several key assays. These findings highlight M344’s therapeutic promise for pediatric neuroblastoma, with implications for reducing tumor growth and improving patient outcomes.

• CLCC1 Identified as Key Host Factor in HSV-1 Nuclear Egress

  2026-05-11

  This study uncovers CLCC1 as an essential host mediator of membrane fusion during herpesvirus (HSV-1) nuclear egress, a previously uncharacterized step in viral maturation. The findings have broad implications for understanding herpesvirus replication and may inform the development of targeted antiviral strategies.

• Polyphyllin H Targets Cholesterol to Reverse Breast Cancer R

  2026-05-10

  This study demonstrates that Polyphyllin H reverses paclitaxel resistance in breast cancer by binding membrane cholesterol, thereby inhibiting both ABCB1 and ABCC3 transporters. The findings offer a mechanistic framework for overcoming multidrug resistance via cholesterol-rich lipid raft disruption, with implications for more effective chemotherapy strategies.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Workflow Gui

  2026-05-09

  E. coli Uracil-DNA Glycosylase (UDG) is a recombinant DNA repair enzyme used to excise uracil residues from DNA, thereby preventing PCR product contamination and supporting DNA damage repair research. This enzyme is strictly for scientific research, not for diagnostic or medical applications, and is ineffective on RNA or DNA oligonucleotides shorter than six bases.

• Phenylmethanesulfonyl fluoride (PMSF): Mechanism & Lab Utili

  2026-05-09

  Phenylmethanesulfonyl fluoride (PMSF) is an irreversible serine protease inhibitor essential for preserving protein integrity during extraction and Western blot sample preparation. PMSF covalently modifies serine residues in target enzymes, but does not affect metalloproteases or most cysteine and aspartic proteases. Its rapid hydrolysis in aqueous solutions requires careful, short-term use, limiting its application window in workflows.

• Reliable CXCR4 Antagonism: BKT140 (BL-8040, TF 14016) in Onc

  2026-05-08

  This article provides scenario-driven guidance for using BKT140 (BL-8040, TF 14016) CXCR4 Antagonist (SKU B7833) in cell viability, stem cell mobilization, and tumor microenvironment research. It addresses real laboratory challenges, compares product quality and usability, and integrates recent literature to support reproducible, data-rich workflows for cancer research.

• JSH-23 and NF-κB Inhibition: A Systems Perspective on Inflam

  2026-05-07

  Explore the unique systems-level impact of JSH-23, a potent NF-κB inhibitor, on inflammation research. This article analyzes advanced mechanisms, recent translational findings, and practical considerations for optimizing your NF-κB pathway studies.

451 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page